A protocol for developing a clinical practice guideline for therapeutic drug monitoring of vancomycin / 华中科技大学学报(医学)(英德文版)
Journal of Huazhong University of Science and Technology (Medical Sciences)
;
(6): 469-472, 2016.
Article
in English
| WPRIM
| ID: wpr-285244
ABSTRACT
This study aimed to develop a guideline for therapeutic drug monitoring (TDM) of vancomycin. We adopted the new guideline definition from the Institute of Medicine (IOM), adhered closely to the six domains of the Appraisal of Guidelines for Research & Evaluation II (AGREE II), and made recommendations based on systematic reviews. We established a Guideline Steering Group and a Guideline Development Group, formulated 12 questions in the form of Population, Intervention, Comparison, Outcome (PICO) and completed a literature search. As far as we know, we will develop the first evidenced-based guideline for vancomycin TDM under the framework of the Grade of Recommendations Assessment, Development and Evaluation (GRADE).
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pathology
/
Staphylococcal Infections
/
Virulence
/
Drug Administration Schedule
/
Pharmacokinetics
/
Vancomycin
/
China
/
Drug Monitoring
/
Evidence-Based Medicine
/
Drug Therapy
Type of study:
Practice guideline
/
Health economic evaluation
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Journal of Huazhong University of Science and Technology (Medical Sciences)
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS